iHuman (IH) EBITDA (2019 - 2026)

iHuman (IH) has reported EBITDA for 8 consecutive years, with -$1.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBITDA fell 148.39% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at $5.0 million (down 54.35% YoY), while the FY2025 annual figure was $9.5 million, down 7.08% from the prior year.
• EBITDA slipped to -$1.5 million in Q1 2026 per IH's latest filing, from $1.3 million in the prior quarter.
• Across five years, EBITDA topped out at $8.6 million in Q1 2023 and bottomed at -$1.5 million in Q1 2026.
• Historically, EBITDA has averaged $3.6 million across 5 years, with a median of $3.0 million in 2025.
• Annual changes were most pronounced in 2022 — EBITDA jumped 2941.32% — and 2026, when it tumbled 148.39%.
• iHuman's EBITDA stood at $6.4 million in 2022, then plunged by 47.2% to $3.4 million in 2023, then plunged by 37.36% to $2.1 million in 2024, then plunged by 37.9% to $1.3 million in 2025, then slumped by 210.64% to -$1.5 million in 2026.
• Business Quant data shows IH's EBITDA at -$1.5 million in Q1 2026, $1.3 million in Q4 2025, and $2.4 million in Q3 2025.